Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

ProfesorCBD

Spanish Medical Cannabis Startup ProfesorCBD Secures Seed Funding for Drug Delivery Device

June 29, 2026 by Marco Bianchi

ProfesorCBD, through its subsidiary Cannabioteacher, has raised 207,000 euros to develop Spain’s first medical cannabis administration device. The funding will support the creation of a medical device designed for medicinal cannabis delivery.

Categories Funding Tags Healthtech, ProfesorCBD, Seed, Spain, Under €1M Leave a comment
Browse by Country

Latest

Danish Climate Tech Fund Climentum Capital Closes €60 Million for Second FundJul 3, 2026
London-based geoSurge secures €10 million seed funding to advance AI brand representation technologyJul 3, 2026
Polish Digital Travel Service Odyseusz Integrated Into Government's mObywatel AppJul 3, 2026
PyTorch Foundation Establishes Independence in Paris to Drive European Open-Source AI DevelopmentJul 3, 2026
Swedish SaaS Startup Blenda Labs Acquired by Epidemic Sound After Just Six MonthsJul 3, 2026

EU Markets

European Markets Send Mixed Signals for Startups: IPO Windows Open, Liquidity Traps Widen, and Crypto Regulation AcceleratesJun 26, 2026
Iran Tensions, AI Bubbles, and a Crypto Reckoning: What Europe's Financial Markets Mean for Your Startup This WeekJun 19, 2026
Mega Rounds, Rate Anxiety, and a Consolidation Wave: What European Founders Need to Know This WeekJun 12, 2026
AI Infrastructure Billions, Banking Consolidation, and a SpaceX IPO Frenzy: What Europe's Financial Markets Mean for Startups This WeekJun 5, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.